Experimental Oncology : Impact Factor & More
eISSN: 2312-8852pISSN: 1812-9269
Share this on:
Key Metrics
CiteScore 
1.6
SJR
Q4Oncology
SNIP
0.34
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Experimental Oncology
Experimental Oncology Journal Specifications
| Overview | |
| Publisher | INST EXP PATHOL ONCOL RADIOBIOL |
| Frequency | Quarterly |
| General Details | |
| Frequency | Quarterly |
| Website URL | Visit website |
View less
Planning to publish in Experimental Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Experimental Oncology
ROLE OF miR-26b-5p AND miR-186-5p IN BREAST CANCER PATIENTS OF YOUNG AGE: CLINICAL ASSOCIATIONS AND RELATION TO ANTHRACYCLINE RESPONSE.
- 5 Mar 2026
- Experimental oncology
SPIKE PROTEIN OF SARS-COV-2 INCREASES CXCR4 EXPRESSION AND MIGRATION OF BREAST CANCER CELLS IN VITRO.
- 5 Mar 2026
- Experimental oncology
NON-STANDARD STRATEGIES IN THE TREATMENT OF ADVANCED CERVICAL CANCER: A CASE SERIES.
- 5 Mar 2026
- Experimental oncology
INTRA-ARTERIAL CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER: A LITERATURE REVIEW.
- 5 Mar 2026
- Experimental oncology
IMPACT OF QUADRATUS LUMBORUM BLOCK AND EPIDURAL ANALGESIA ON FUNCTIONAL RECOVERY OF THE LIVER AFTER SURGICAL RESECTION FOR COLORECTAL LIVER METASTASES.
- 5 Mar 2026
- Experimental oncology
CLINICAL CASE OF COMPLEX RADICAL TREATMENT OF METASTATIC PROGRESSION TO RARE SITE OF PRIMARY ORGAN CONFINED CHROMOPHOBE RENAL CELL CARCINOMA TREATED WITH LAPAROSCOPIC PARTIAL NEPHRECTOMY.
- 5 Mar 2026
- Experimental oncology
ROLE OF miR-26b-5p AND miR-186-5p IN BREAST CANCER PATIENTS OF YOUNG AGE: CLINICAL ASSOCIATIONS AND RELATION TO ANTHRACYCLINE RESPONSE.
- 5 Mar 2026
- Experimental oncology
SPIKE PROTEIN OF SARS-COV-2 INCREASES CXCR4 EXPRESSION AND MIGRATION OF BREAST CANCER CELLS IN VITRO.
- 5 Mar 2026
- Experimental oncology
NON-STANDARD STRATEGIES IN THE TREATMENT OF ADVANCED CERVICAL CANCER: A CASE SERIES.
- 5 Mar 2026
- Experimental oncology
INTRA-ARTERIAL CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER: A LITERATURE REVIEW.
- 5 Mar 2026
- Experimental oncology
IMPACT OF QUADRATUS LUMBORUM BLOCK AND EPIDURAL ANALGESIA ON FUNCTIONAL RECOVERY OF THE LIVER AFTER SURGICAL RESECTION FOR COLORECTAL LIVER METASTASES.
- 5 Mar 2026
- Experimental oncology
CLINICAL CASE OF COMPLEX RADICAL TREATMENT OF METASTATIC PROGRESSION TO RARE SITE OF PRIMARY ORGAN CONFINED CHROMOPHOBE RENAL CELL CARCINOMA TREATED WITH LAPAROSCOPIC PARTIAL NEPHRECTOMY.
- 5 Mar 2026
- Experimental oncology
FAQs on Experimental Oncology
What is the publishing frequency of Experimental Oncology? 
How many articles did Experimental Oncology publish last year?
What is the eISSN & pISSN for Experimental Oncology?
What is Citescore for Experimental Oncology?
What is SNIP score for Experimental Oncology?
What is the SJR for Experimental Oncology?
Who is the publisher of Experimental Oncology?
